Hans Deckmyn
#165,846
Most Influential Person Now
Researcher
Hans Deckmyn's AcademicInfluence.com Rankings
Hans Deckmyncomputer-science Degrees
Computer Science
#9933
World Rank
#10421
Historical Rank
Artificial Intelligence
#4837
World Rank
#4900
Historical Rank
Database
#6885
World Rank
#7126
Historical Rank
Download Badge
Computer Science
Hans Deckmyn's Degrees
- PhD Computer Science Delft University of Technology
- Masters Artificial Intelligence University of Amsterdam
- Bachelors Computer Science University of Amsterdam
Similar Degrees You Can Earn
Why Is Hans Deckmyn Influential?
(Suggest an Edit or Addition)Hans Deckmyn's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The metabolism of phosphoinositide-derived messenger molecules. (1986) (583)
- Platelets at work in primary hemostasis. (2011) (367)
- THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTS (1985) (302)
- Neutrophil extracellular traps in ischemic stroke thrombi (2017) (283)
- Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. (2004) (202)
- The hemostatic system. (2004) (186)
- Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. (1994) (185)
- MK‐383 (L‐700,462), a Selective Nonpeptide Platelet Glycoprotein 1Ib/IIIa Antagonist, Is Active in Man (1993) (164)
- A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2. (1982) (163)
- PROLONGING PROSTACYCLIN PRODUCTION BY NAFAZATROM OR DIPYRIDAMOLE (1984) (156)
- Deficiency of von Willebrand factor protects mice from ischemic stroke. (2009) (156)
- Matrix-specific suppression of integrin activation in shear stress signaling. (2006) (149)
- Dipyridamole Inhibits Platelet Aggregation in Whole Blood (1983) (145)
- Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure* (2007) (145)
- Pharmacokinetics and pharmacodynamics of MK‐383, a selective non‐peptide platelet glycoprotein‐IIb/IIIa receptor antagonist, in healthy men (1994) (138)
- von Willebrand factor to the rescue. (2009) (138)
- ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis (2007) (136)
- Shielding of the A1 Domain by the D′D3 Domains of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V* (2006) (131)
- Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates. (2000) (128)
- Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism. (1987) (125)
- Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders. (1991) (123)
- Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance (2019) (119)
- ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice. (2016) (118)
- Mechanism of the Antiplatelet Action of Dipyridamole in Whole Blood: Modulation of Adenosine Concentration and Activity (1986) (117)
- Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons. (2002) (115)
- Platelet adhesion to collagen. (2011) (114)
- Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus). (2010) (110)
- Lack of Platelet Response to Collagen Associated with an Autoantibody against Glycoprotein Ia: A Novel Cause of Acquired Qualitative Platelet Dysfunction (1989) (103)
- A Reliable and Reproducible ELISA Method to Measure Ristocetin Cofactor Activity of von Willebrand Factor (2000) (103)
- ADAMTS‐13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences (2006) (102)
- von Willebrand factor binds to native collagen VI primarily via its A1 domain. (1997) (101)
- Inherited traits affecting platelet function. (2008) (101)
- Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function. (2010) (98)
- Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2. (1984) (97)
- The platelet insulin receptor: detection, partial characterization, and search for a function. (1988) (89)
- Synergistic Effect of Thrombin on Collagen-Induced Platelet Procoagulant Activity Is Mediated Through Protease-Activated Receptor-1 (2005) (87)
- Multiple ways to switch platelet integrins on and off (2008) (86)
- Characterization of N,N’-bis(3-Picolyl)-4-Methoxy-Isophtalamide (Picotamide) as a Dual Thromboxane Synthase Inhibitor/Thromboxane A2 Receptor Antagonist in Human Platelets (1989) (86)
- Blood platelet biochemistry. (2012) (85)
- Thrombosis and immune disorders. (1986) (85)
- Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins (2008) (83)
- Guanine nucleotides stimulate soluble phosphoinositide-specific phospholipase C in the absence of membranes. (1986) (81)
- Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha. (2001) (81)
- BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN (1984) (75)
- Inhibition of Platelet Glycoprotein Ib, Glycoprotein IIb/IIIa, or Both by Monoclonal Antibodies Prevents Arterial Thrombosis in Baboons (2002) (75)
- Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor. (2006) (75)
- Restoration of Plasma von Willebrand Factor Deficiency Is Sufficient to Correct Thrombus Formation After Gene Therapy for Severe von Willebrand Disease (2008) (74)
- Principal Role of Glycoprotein VI in &agr;2&bgr;1 and &agr;IIb&bgr;3 Activation During Collagen-Induced Thrombus Formation (2004) (73)
- Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in mice. (2015) (68)
- Binding of von Willebrand Factor to Collagen and Glycoprotein Ib&agr;, But Not to Glycoprotein IIb/IIIa, Contributes to Ischemic Stroke in Mice—Brief Report (2010) (67)
- Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. (2011) (66)
- Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans. (2018) (64)
- Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer (2020) (64)
- The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons (2008) (64)
- Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions. (1995) (63)
- Macroporous monolithic gels, cryogels, with immobilized phages from phage-display library as a new platform for fast development of affinity adsorbent capable of target capture from crude feeds. (2007) (62)
- Disturbed platelet aggregation to collagen associated with an antibody against an 85- to 90-Kd platelet glycoprotein in a patient with prolonged bleeding time. (1991) (60)
- Laboratory Diagnosis and Molecular Classification of von Willebrand Disease (2009) (57)
- Leukotriene B4 production by stimulated whole blood: comparative studies with isolated polymorphonuclear cells. (1986) (56)
- Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters. (1995) (54)
- An open conformation of ADAMTS‐13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura (2018) (54)
- Identification of Residues within Human Glycoprotein VI Involved in the Binding to Collagen (2004) (53)
- Shear-dependent morphology of von Willebrand factor bound to immobilized collagen. (2002) (52)
- The von Willebrand factor self‐association is modulated by a multiple domain interaction (2005) (52)
- Glycoprotein Ibα inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques (2007) (52)
- Inhibition of platelet glycoprotein Ib and its antithrombotic potential. (2007) (52)
- Platelet activation. (1995) (51)
- Immobilised peptide displaying phages as affinity ligands. Purification of lactoferrin from defatted milk. (2006) (51)
- Continuous Quantitative Monitoring of Mural, Platelet-Dependent, Thrombus Kinetics in the Crushed Rat Femoral Vein (1991) (50)
- Thromboxane Synthase Inhibition Combined with Thromboxane Receptor Blockade: A Step Forward in Antithrombotic Strategy? (1984) (49)
- Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets. (2018) (49)
- Appropriation of GPIbα from platelet-derived extracellular vesicles supports monocyte recruitment in systemic inflammation (2019) (49)
- Local Elongation of Endothelial Cell-anchored von Willebrand Factor Strings Precedes ADAMTS13 Protein-mediated Proteolysis* (2011) (49)
- Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders. (1988) (49)
- Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS‐13 (2015) (48)
- Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons. (2012) (48)
- Antiplatelet drugs (2008) (47)
- Activation of αIIbβ3 is a sufficient but also an imperative prerequisite for activation of α2β1 on platelets (2007) (46)
- N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura. (2017) (45)
- Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation. (2004) (45)
- von Willebrand factor binds to native collagen VI primarily via its A 1 domain (1997) (45)
- New Insights into von Willebrand Disease and Platelet Function (2012) (44)
- Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatrom. (1983) (44)
- Normal mechanisms of platelet function. (1983) (44)
- An echistatin‐like Arg‐Gly‐Asp (RGD)‐containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function (1994) (44)
- Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor-1 Reduces Ischemic Brain Damage in Mice (2016) (44)
- Two Functional Active Conformations of the Integrin α2β1, Depending on Activation Condition and Cell Type* (2005) (42)
- Inhibition of platelet adhesion to collagen as a new target for antithrombotic drugs. (2003) (41)
- A Consensus Tetrapeptide Selected by Phage Display Adopts the Conformation of a Dominant Discontinuous Epitope of a Monoclonal Anti-VWF Antibody That Inhibits the von Willebrand Factor-Collagen Interaction* (2003) (41)
- Von Willebrand Factor But Not &agr;-Thrombin Binding to Platelet Glycoprotein Ib&agr; Is Influenced by the HPA-2 Polymorphism (2003) (40)
- Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura (2010) (39)
- Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor. (1998) (39)
- Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin. (1995) (39)
- Human platelet aggregation by murine monoclonal antiplatelet antibodies is subtype-dependent. (1993) (39)
- Monoclonal antibody IAC-1 is specific for activated alpha2beta1 and binds to amino acids 199 to 201 of the integrin alpha2 I-domain. (2004) (38)
- R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin (1990) (37)
- Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIbα (2006) (37)
- Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura. (2020) (37)
- Collagen‐mimetic peptides mediate flow‐dependent thrombus formation by high‐ or low‐affinity binding of integrin α2β1 and glycoprotein VI (2008) (37)
- Chromato-panning: an efficient new mode of identifying suitable ligands from phage display libraries (2009) (35)
- The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet‐decorated VWF strings in vivo (2010) (34)
- Effects of thromboxane A2 on lymphocyte proliferation. (1985) (33)
- Improved platelet survival after cold storage by prevention of glycoprotein Ibα clustering in lipid rafts (2012) (33)
- Protective Effect of Vitamin E on Immune Triggered, Granulocyte Mediated Endothelial Injury (1984) (32)
- Functional effects of human antiplatelet antibodies. (1995) (32)
- Role of glycoprotein Ibα in phagocytosis of platelets by macrophages (2006) (32)
- The CX3C chemokine fractalkine mediates platelet adhesion via the von Willebrand receptor glycoprotein Ib. (2011) (32)
- The Collagen-binding Leech Products rLAPP and Calin Prevent both von Willebrand Factor and α2β1 (GPIa/IIa)-I-domain Binding to Collagen in a Different Manner (1999) (32)
- Rational humanization of the powerful antithrombotic anti-GPIbα antibody: 6B4 (2006) (31)
- Sodium fluoride mimics effects of both agonists and antagonists on intact human platelets by simultaneous modulation of phospholipase C and adenylate cyclase activity (1987) (30)
- Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains. (2006) (30)
- Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs. (2006) (30)
- Platelet antigens and their function (2004) (29)
- Paratope Determination of the Antithrombotic Antibody 82D6A3 Based on the Crystal Structure of Its Complex with the von Willebrand Factor A3-Domain* (2006) (29)
- Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease (2017) (28)
- Laser-induced primary and secondary hemostasis dynamics and mechanisms in relation to selective photothermolysis of port wine stains. (2011) (27)
- Choline Transporter-Like Protein-2: New von Willebrand Factor-Binding Partner Involved in Antibody-Mediated Neutrophil Activation and Transfusion-Related Acute Lung Injury. (2015) (27)
- Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34(+) cells are functionally active in an ex vivo flow model of thrombosis. (2009) (27)
- Structural determinants within platelet glycoprotein Ibalpha involved in its binding to von Willebrand factor. (2000) (27)
- Von Willebrand factor: drug and drug target. (2009) (27)
- Reorientation of prostaglandin endoperoxide metabolism by a thromboxane synthetase inhibitor: in vitro and clinical observations. (1983) (27)
- The GPIbα–thrombin interaction: far from crystal clear (2004) (26)
- Platelet interaction with von Willebrand factor is enhanced by shear-induced clustering of glycoprotein Ibα (2013) (26)
- Affinity comparison of p3 and p8 peptide displaying bacteriophages using surface plasmon resonance. (2013) (26)
- Enkephalins Modify Granulocyte-Endothelial Interactions by Stimulating Prostacyclin Production (1983) (26)
- Production and nucleotide sequence of an inhibitory human IgM autoantibody directed against platelet glycoprotein Ia/IIa. (1994) (25)
- New model of transient strain-dependent autoimmune thrombocytopenia in mice immunized with rat platelets. (2004) (25)
- The role of platelet and endothelial GARP in thrombosis and hemostasis (2017) (24)
- Partial isolation and function of the prostacyclin regulating plasma factor. (1985) (24)
- Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Ibα and Fc RIIa in immune thrombocytopenia (2013) (24)
- Plasma glycocalicin as a source of GPIbα in the von Willebrand factor ristocetin cofactor ELISA (2004) (23)
- Platelet sequestration and activation during GalTKO.hCD46 pig lung perfusion by human blood is primarily mediated by GPIb, GPIIb/IIIa, and von Willebrand Factor (2016) (23)
- The integrin alpha 2 beta 1 (GPIa/IIa)-I-domain inhibits platelet-collagen interaction. (1997) (23)
- Fast and Reproducible Vascular Neointima Formation in the Hamster Carotid Artery: Effects of Trapidil and Captopril (1995) (23)
- Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function. (2020) (22)
- A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains. (1993) (21)
- Pig‐to‐baboon liver xenoperfusion utilizing GalTKO.hCD46 pigs and glycoprotein Ib blockade (2014) (21)
- Activation of alphaIIbbeta3 is a sufficient but also an imperative prerequisite for activation of alpha2beta1 on platelets. (2007) (21)
- The novel ADAMTS13‐p.D187H mutation impairs ADAMTS13 activity and secretion and contributes to thrombotic thrombocytopenic purpura in mice (2015) (21)
- Occurrence of the Asn45Ser mutation in the GPIX gene in a Belgian patient with Bernard Soulier syndrome (2001) (20)
- ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura – current perspectives and new treatment strategies (2016) (20)
- How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects? (2005) (20)
- Fc-receptor Dependent Platelet Aggregation Induced by Monoclonal Antibodies against Platelet Glycoprotein Ib or von Willebrand Factor (2001) (20)
- Platelets from flowing blood attach to the inflammatory chemokine CXCL16 expressed in the endothelium of the human vessel wall (2015) (20)
- Rational humanization of the powerful antithrombotic anti-GPIbalpha antibody: 6B4. (2006) (20)
- Desmopressin treatment improves platelet function under flow in patients with postoperative bleeding (2015) (19)
- Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIIa antibody 7E3 in a canine arterial eversion graft preparation. (1994) (19)
- Platelet hypersensitivity to serotonin after prolonged ketanserin intake? (1985) (19)
- A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease. (2002) (19)
- The Integrin α2β1 (GPIa/IIa)-I-Domain Inhibits Platelet-Collagen Interaction (1997) (19)
- Two functional active conformations of the integrin {alpha}2{beta}1, depending on activation condition and cell type. (2005) (19)
- Guanine nucleotide-dependent inhibition of phospholipase C in human endothelial cells. (1990) (18)
- Ridogrel, a Combined Thromboxane Synthase Inhibitor and Receptor Blocker, Decreases Elevated Plasma β-Thromboglobulin Levels in Patients with Documented Peripheral Arterial Disease (1990) (18)
- Immunomodulatory effects of treatment with naproxen in patients with rheumatic disease. (1986) (18)
- The Novel S527F Mutation in the Integrin β3 Chain Induces a High Affinity αIIbβ3 Receptor by Hindering Adoption of the Bent Conformation* (2009) (18)
- Paratope and Epitope Mapping of the Antithrombotic Antibody 6B4 in Complex with Platelet Glycoprotein Ibα* (2007) (18)
- Model systems of genetically modified platelets. (2012) (18)
- Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura (2018) (18)
- Measurement of von Willebrand factor antigen in plasma and platelets with an enzyme-linked immunosorbent assay based on two murine monoclonal antibodies. (1991) (18)
- Identification of peptides, selected by phage display technology, that inhibit von Willebrand factor binding to collagen. (1998) (18)
- von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism. (2003) (18)
- On the interaction of fluorophore-encapsulating PEGylated lecithin liposomes with hamster and human platelets. (2009) (17)
- Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura (2016) (16)
- ADAMTS13 in Health and Disease (2009) (16)
- Prostacyclin production in whole blood throughout normal pregnancy. (1983) (16)
- R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin. (1990) (16)
- Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibα in an enzyme‐linked immunosorbent assay‐based method: performances in patients with type 2B von Willebrand disease (2006) (16)
- Long-Term Prevention of Congenital Thrombotic Thrombocytopenic Purpura in ADAMTS13 Knockout Mice by Sleeping Beauty Transposon-Mediated Gene Therapy (2017) (16)
- Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura. (2009) (16)
- A probe for capture and Fe3+-induced conformational change of lactoferrin selected from phage displayed peptide libraries. (2004) (16)
- Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor - collagen interaction in baboons (2007) (16)
- Influence of a vitamin E-deficient diet on prostacyclin production by mesometrial triangles and aortic rings from nondiabetic and diabetic pregnant rats. (1985) (15)
- Platelet physiology and antiplatelet agents (2010) (15)
- Inhibitory Effect of Piracetam on Platelet-rich Thrombus Formation in an Animal Model (1998) (15)
- High and long‐term von Willebrand factor expression after Sleeping Beauty transposon‐mediated gene therapy in a mouse model of severe von Willebrand disease (2018) (14)
- Identification of a Collagen-Binding Protein from Necator americanus by Using a cDNA-Expression Phage Display Library (2001) (14)
- Identification of a Small Molecule That Modulates Platelet Glycoprotein Ib-von Willebrand Factor Interaction* (2012) (14)
- COMBINING ANTIPLATELET AGENTS: POTENTIATION BETWEEN ASPIRIN AND DIPYRIDAMOLE (1985) (14)
- A monoclonal antibody directed against human von Willebrand factor induces type 2B‐like alterations (2004) (14)
- Characterization of Murine Anti-Glycoprotein Ib Monoclonal Antibodies That Differentiate between Shear-Induced and Ristocetin/Botrocetin-Induced Glycoprotein Ib-von Willebrand Factor Interaction (2000) (14)
- L-652,343, a novel dual cyclo/lipoxygenase inhibitor, inhibits LTB4-production by stimulated human polymorphonuclear cells but not by stimulated human whole blood. (1987) (14)
- False positive results in chimeraplasty for von Willebrand Disease. (2007) (14)
- The von Willebrand Factor A1 domain mediates thromboinflammation, aggravating ischemic stroke outcome in mice. (2020) (14)
- Prolonged Inhibition of Acute Arterial Thrombosis by High Dosing of a Monoclonal Anti-platelet Glycoprotein IIb/IIIa Antibody in a Baboon Model (1995) (14)
- Prostacyclin in pregnancy. (1984) (13)
- BM 13.177 selectively inhibits endoperoxide analogue induced vascular contractions. (1985) (13)
- Inhibitory and activating human antiplatelet antibodies. (1998) (13)
- The A/T1381 polymorphism in the A1-domain of von Willebrand factor influences the affinity of von Willebrand factor for platelet glycoprotein Ibα (2007) (13)
- Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice (2017) (13)
- Sickle cell disease and COVID‐19: Atypical presentations and favorable outcomes (2020) (13)
- The Parasitic Hematophagous Worm Haemonchus contortus Inhibits Human Platelet Aggregation and Adhesion: Partial Purification of a Platelet Inhibitor (2002) (13)
- Shielding of the A 1 Domain by the D D 3 Domains of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein (2006) (13)
- Fluorescent labeling of platelets with polyanionic fluorescein derivatives. (2009) (12)
- The GPIbalpha-thrombin interaction: far from crystal clear. (2004) (12)
- Type 2B von Willebrand disease in seven individuals from three different families: Phenotypic and genotypic characterization (2007) (12)
- Anti-ADAMTS13 Antibodies and a Novel Heterozygous p.R1177Q Mutation in a Case of Pregnancy-Onset Immune-Mediated Thrombotic Thrombocytopenic Purpura (2018) (11)
- 5 Inhibitory and activating human antiplatelet antibodies (1998) (11)
- Udcg 115 and 212, 2 benzimidazo-pyridazinones with broad-spectrum antiplatelet activity (1985) (11)
- A Monoclonal Antibody to Platelet Type III Collagen-binding Protein (TIIICBP) Binds to Blood and Vascular Cells, and Inhibits Platelet Vessel-wall Interactions (2001) (11)
- Development of a high-throughput ELISA assay for platelet function testing using platelet-rich plasma or whole blood (2010) (11)
- Selection of Phages that Inhibit vWF Interaction with Collagen under both Static and Flow Conditions (2001) (11)
- Inhibitors of the interactions between collagen and its receptors on platelets. (2012) (10)
- Deletion of GARP on mouse regulatory T cells is not sufficient to inhibit the growth of transplanted tumors. (2018) (10)
- Synergistic Antiplatelet Effect of Ridogrel, a Combined Thromboxane Receptor Antagonist and Thromboxane Synthase Inhibitor, and UDCG-212, a cAMP-Phosphodiesterase Inhibitor (1993) (10)
- Fc-independent cross-linking of a novel platelet membrane protein by a monoclonal antibody causes platelet activation. (1994) (10)
- Low prostacyclin synthetase activity of fetal rat aorta. Progressive increase after birth. (1983) (10)
- In vivo von Willebrand factor size heterogeneity in spite of the clinical deficiency of ADAMTS‐13 (2011) (10)
- Blood Changes and Enhanced Thromboxane and 6-Keto Prostaglandin F1α Production in Experimental Acute Plasmodium Bergei Infection in Hamsters (1984) (10)
- Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation (2018) (10)
- Acute effect of cigarette smoking on cardiac prostaglandin synthesis and platelet behavior in patients with coronary heart disease. (1983) (10)
- Integrin alphaIIbbeta3 and shear-dependent action of glycoprotein Ibalpha stimulate platelet-dependent thrombin formation in stirred plasma. (2003) (10)
- Thromboxane synthase inhibitors and receptor antagonists (1992) (9)
- Development of antibodies that interfere with the collagen-VWF-GPIb axis as new antithrombotics. (2005) (9)
- Prostacyclin production by whole blood from children: impairment in the hemolytic uremic syndrome and excessive formation in chronic renal failure. (1983) (9)
- CHAPTER 18 – Phosphatidylinositol Phospholipase C (1990) (8)
- Glycoprotein VI is not a Functional Platelet Receptor for Fibrin Formed in Plasma or Blood (2020) (8)
- Experimental indication for the existence of multiple Trp rotamers in von Willebrand Factor A3 domain (2004) (8)
- Intravenous ionic contrast media cause local prostacyclin release in man. (1985) (8)
- Assays for quality control of platelets for transfusion (2013) (8)
- von Willebrand factor in experimental malaria‐associated acute respiratory distress syndrome (2019) (8)
- Thromboxane A2 and prostacyclin do not modulate the systemic hemodynamic response to cold in humans. (1985) (8)
- Crucial Role for Endothelial Cell α2β1 Integrin Receptor Clustering in Collagen‐Induced Angiogenesis (2019) (8)
- Characterisation of a Novel Series of Aprotinin-derived Anticoagulants (1995) (8)
- An integrated fragment based screening approach for the discovery of small molecule modulators of the VWF-GPIbα interaction. (2012) (8)
- PLATELET INHIBITORY ACTIVITY OF PROSTACYCLIN IN THE PRESENCE OF ERYTHROCYTES AS STUDIED WITH THE IMPEDANCE AGGREGOMETER (1984) (7)
- Anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura do not hamper ELISA‐based quantification of ADAMTS13 antigen (2020) (7)
- Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome (2018) (7)
- Von Willebrand Factor Antigen Latex Immunoassays are Affected to a Different Extent by Rheumatoid Factor (2006) (7)
- Identification of a VWF peptide antagonist that blocks platelet adhesion under high shear conditions by selectively inhibiting the VWF‐collagen interaction (2009) (7)
- The effect of plasmin on platelet function. (1996) (7)
- Platelets and PEGylated lecithin liposomes: when stealth is allegedly picked up on the radar (and eaten). (2009) (7)
- Sequence Alignment between vWF and Peptides Inhibiting the vWF-collagen Interaction Does not Result in the Identification of a Collagen-binding Site in vWF (2000) (7)
- New approaches for antithrombotic antiplatelet therapies. (2004) (7)
- Prostacyclin (pgi2) production by aortic rings and mesometrial triangles in pregnant rats, fed an anti-vitamin-e stress diet (1983) (6)
- Endogenous antiaggregatory prostaglandins can contribute to inhibition of hemostasis: a pharmacological study in vivo in humans. (1987) (6)
- Human platelet aggregation by murine monoclonal antibodies is subtype-dependent (1993) (6)
- Production and nucleotide-sequence of an inhibitory human-igm autoantibody directed against platelet glycoprotein-ia (1993) (6)
- Differential regulation of the platelet GPIb‐IX complex by anti‐GPIbβ antibodies (2021) (6)
- Roles of Src-like adaptor protein 2 (SLAP-2) in GPVI-mediated platelet activation SLAP-2 and GPVI signaling. (2010) (6)
- Dual Regulation of Phospolipase C Activity by G Proteins (1993) (6)
- Influence of products of the cyclo-oxygenase pathway on platelet shape change (1985) (6)
- The prostacyclin stimulating plasma factor (pspf) protects endothelial-cells from exhaustion (1983) (6)
- Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients (2018) (6)
- Continuous inhibition of the platelet S2-serotonergic receptors during the long term administration of ketanserin. (1986) (6)
- R68070, a combined thromboxane synthase (tsi) and receptor blocker (tra), reduces thrombus formation in rats (1989) (6)
- G4120, a rgd-containing cyclic pentapeptide, prevents neointima formation in injured hamster carotid arteries (1993) (5)
- Continuous inhibition of serotonin-induced platelet aggregation during chronic ketanserin administration to man can be detected after plasma pH control. (1987) (5)
- PILOT EVALUATION OF ANTI-GPIB EFFECTS ON PLATELET SEQUESTRATION IN AN EX VIVO XENOGENEIC PIG LIVER PERFUSION MODEL: 3132 (2010) (5)
- Responder-nonresponder behavior of human-platelets towards thromboxane synthase inhibitors (tsi) is due to difference in adenylate-cyclase sensitivity (1985) (5)
- Choline Transporter-Like Protein-2Significance (2015) (5)
- Blood changes and enhanced thromboxane-b2 and 6-keto prostaglandin production in acute plasmodium-bergei infection in hamsters (1983) (5)
- Synthesis and modifications of a small library of 1,4-benzodiazepin-3-ones toward potential inhibitors of the collagen—von Willebrand Factor interaction (2009) (5)
- Development and screening of epoxy-spacer-phage cryogels for affinity chromatography: Enhancing the binding capacity. (2017) (5)
- Anti-vWf antibodies induce GPIbalpha and FcgammaRII mediated platelet aggregation only at low shear forces. (2001) (4)
- Phosphoinositide metabolism in human platelets. (1987) (4)
- 295 Blocking GP1b-vWF Interaction by Anti-GP1b Fab Reduces Activation and Sequestration of Platelets in a Xenogeneic Pig Lung Perfusion Model (2011) (4)
- Pai-1 is not synthesized in human platelets (1991) (4)
- When collagen meets VWF (2006) (4)
- Acquired Bernard-Soulier Syndrome: A Case with Necrotizing Vasculitis and Thrombosis (1999) (4)
- The effect of sulphinpyrazone on whole blood thromboxane and prostacyclin generation in man. (1982) (4)
- Fc-independent cross-linking of a novel platelet membrane protein by a monoclonal antibody causes platelet activation (1994) (4)
- Epinephrine induces a late thromboxane-dependent platelet shape change and enhances synergistically the shape change induced by other platelet agonists. (1995) (3)
- von Willebrand factor deficiency does not influence angiotensin II-induced abdominal aortic aneurysm formation in mice (2018) (3)
- Influence of prostaglandin E2 and indomethacin on interferon-γ production by cultured peripheral blood leukocytes of multiple sclerosis patients and healthy donors (1985) (3)
- The role of VWF-collagen interaction in acute platelet thrombus formation (2003) (3)
- Comparative properties of a factor-xa inhibitor, 4c2 (an aprotonin analog), heparin and hirudin in a hamster femoral vein platelet-rich mural thrombosis model (1993) (3)
- Lack of synergism between dazoxiben and dipyridamole following administration to man. (1985) (3)
- A platelet-activating antiglycoprotein Ib monoclonal antibody. (1997) (3)
- A murine monoclonal-antibody against platelet glycoprotein iib iiia potently inhibits platelet functioning invitro and invivo (1991) (3)
- Manipulation of the local thromboxane and prostacyclin balance invivo by anti-thrombotic compounds (1983) (3)
- Pharmacological manipulation of the thromboxane pathway in blood platelets. (1990) (3)
- Human ex-vivo, threshold u46619 induced platelet-aggregation is inhibited after bier block and epidural-anesthesia with xylocaine (1993) (3)
- On the role of guanine nucleotide binding regulatory proteins (G-proteins) in signal transduction in human platelets: studies with sodium fluoride (NaF). (1986) (3)
- Human platelet activation-induced by antibody-mediated cross-linking of a novel platelet receptor (1993) (2)
- A murine monoclonal-antibody against vonwillebrand-factor (vwf) increases vwf binding to human platelet glycoprotein (gp) ib and gp iib/iiia (1991) (2)
- Thrombosis as an integral part of endovascular laser-tissue interactions (2006) (2)
- Distinct sequences of the glycoprotein Ib-binding domain of von Willebrand factor involved in shear induced platelet aggregation. (1998) (2)
- Anti-vWf Antibodies Induce GPIbα and FcγRII Mediated Platelet Aggregation Only at Low Shear Forces (2004) (2)
- Inhibitors of Platelet Adhesion to VWF and Collagen (2017) (2)
- Platelets activated locally in vivo regulate prostacyclin production by vessel wall (1985) (2)
- Antithrombotic Potential of Thromboxane Synthase Inhibitors: Problems and Possible Solutions (1985) (2)
- [Determination of the ADAMTS13 antigen and its activity in TTP patients and carriers]. (2006) (2)
- Child‐onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13 (2018) (2)
- Exposure of von Willebrand factor on isolated hepatocytes promotes tethering of platelets to the cell surface. (2019) (2)
- Influence of the prostacyclin regulating plasma factor on human vascular endothelium in a microcirculation model (1985) (2)
- Commercially available intravenous immunoglobulins (iv igs) inhibit binding of anti-glycoprotein (gp)iib-iiia antibodies to their antigens in chronic idiopathic thrombocytopenic purpura (itp) patients (1991) (2)
- Sodium fluoride mimics effects of both agonists and antagonists on intact human platelets by simultaneous modulation of phospholipase C and adenylate cyclase activity. (1987) (2)
- ADAMTS13 LEVELS IN HIV INFECTED PATIENTS WITH AND WITHOUT TTP (2009) (2)
- Platelet Functional Genomics (2011) (2)
- von Willebrand factor increases in experimental cerebral malaria but is not essential for late‐stage pathogenesis in mice (2020) (2)
- Synergistic effect of udcg212, a phosphodiesterase inhibitor (pde-i), and r68070, a combined thromboxane receptor antagonist (tra) and thromboxane synthase inhibitor (tsi), on platelet camp levels (1989) (2)
- Dipyridamole inhibits platelet-aggregation in whole-blood invitro and exvivo (1983) (2)
- While not essential for normal thrombosis and hemostasis , platelet-derived VWF fosters ischemic stroke injury in mice (2015) (2)
- Humanized monoclonal antibody 6B4 Fab inhibits GP1B-vWF-mediated human platelet aggregation by porcine plasma (2009) (2)
- Sodium fluoride induced activation of phospholipase C in intact human platelets does not depend on ADP, PAF or arachidonate products. (1993) (2)
- Humanization by Resurfacing (2010) (2)
- Measurement of vonwillebrand-factor antigen in plasma and platelets with an enzyme-linked-immunosorbent-assay based on 2 murine monoclonal-antibodies (1991) (1)
- THROMBOSIS IN INJURED SMALL VESSELS (1991) (1)
- The role of platelet von Willebrand factor in mice (2013) (1)
- RESTORATION OF VON WILLEBRAND FACTOR FUNCTION IN A MURINE MODEL OF SEVERE VON WILLEBRAND DISEASE AFTER LIVER SPECIFIC GENE TRANSFER (2007) (1)
- THROMBOSIS AND HEMOSTASIS ADAMTS 13-mediated thrombolysis of tPA – resistant occlusions in ischemic stroke in mice (2016) (1)
- Recirculated normal platelets adhere to surfaces coated with plasma from patients with immune thrombocytopenia. (1997) (1)
- Apparent heterogeneity in the pIII-peptide fusion protein in single-phage clones isolated from peptide libraries. (2011) (1)
- Correlation between initial thrombus size and neointima formation in the damaged hamster carotid-artery (1995) (1)
- A monoclonal antibody to the alpha 2 integrin subunit cross-reacts with RGD-dependent epitopes in fibrinogen. (1993) (1)
- Reorientation of cyclic endoperoxide metabolism and efficacy of thromboxane synthetase inhibitors (tsi) (1983) (1)
- Prostacyclin stimulatory activity of reducing cofactors in human plasma filtrate. A potential role for uric acid (1987) (1)
- [Inhibition of integrin function prevents restenosis following vascular injury]. (1995) (1)
- YS02 Screening and Characterisation of Novel Platelet Candidate Genes Derived from Genome‐Wide Association Studies for Function in Relation to Haemostasis and Thrombosis in the Model Organism Danio Rerio (2006) (1)
- Dose-Dependent Inhibition of Acute Arterial Thrombosis by Monoclonal Antibody (16N7C2) in a Baboon Model (1994) (1)
- Inhibition of endothelial prostacyclin production by a guanine-nucleotide dependent inhibition of phospholipase-c (1989) (1)
- Anti-GPIb and anti-vWF monoclonal antibodies activate platelets by crosslinking GPIb with Fc gamma RII (1999) (1)
- Single Particle Tracking of ADAMTS13 (A Disintegrin and Metalloprotease with Thrombospondin Type-1 Repeats) Molecules on Endothelial von Willebrand Factor Strings* (2014) (1)
- Absence of plasminogen activator inhibitor type I (PAI-1) in a human platelet-derived λgtII expression library (1992) (1)
- [Signal transduction in blood platelets]. (1991) (1)
- 295 Combined aGPIb and aGPIIb/IIIa Blockade Prevents Platelet Sequestration in a Pig-to-Human Lung Perfusion Model (2012) (1)
- Artificial MiRNA Knockdown of Platelet Glycoprotein lbα: A Tool for Platelet Gene Silencing (2015) (1)
- The newly identified platelet receptor DCBLD2 is involved in platelet activation and thrombus formation (2013) (1)
- Long-term gene therapy for thrombotic thrombocytopenic purpura using the 'Sleeping Beauty' transposon system (2015) (1)
- collagen, prevents platelet-rich thrombosis in hamsters Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to (2011) (1)
- Platelet integrin α2 I-domain specific antibodies produced via domain specific DNA vaccination combined with variable gene phage display (2005) (1)
- ANTI-GPIB FAB REDUCES ACTIVATION AND SEQUESTRATION OF HUMAN PLATELETS IN A XENOGENEIC PIG LUNG PERFUSION MODEL: 3099 (2010) (1)
- Acquired von Willebrand syndrome in patients on long-term left ventricular assist device support: Results of a Belgian center. (2019) (1)
- An easy method to detect patients with vonwillebrand-factor defective in fviii-binding (1991) (1)
- Advances in a life-supporting xenogenic lung transplant model (2013) (1)
- Functional Genomics for the Identification of Modulators of Platelet-Dependent Thrombus Formation (2018) (1)
- CTL-2 is a new von Willebrand receptor: role in antibody mediated neutrophil aggregation induced by anti-CTL-2 antibodies (2013) (1)
- DUAL EFFECT OF FLUORIDE ON ENDOTHELIAL PROSTACYCLIN PRODUCTION (1987) (1)
- The antithrombotic effects of calin, a platelet-adhesion inhibitor from the medicinal leech, in a hamster femoral vein platelet-rich mural thrombosis model (1993) (1)
- The role of phosphoinositides in cell physiology. (1986) (1)
- The Metabolism of Inositol Phosphates (1988) (0)
- Detection factor activity von-Willebrand factor (vWF). (2000) (0)
- Phage displayed 6-mer mimotopes with a consensus proline absent in the minimized linear wild-type epitope (1998) (0)
- GARP expressed on platelets does not contribute to hemostasis and thrombosis in mice (2015) (0)
- Identification of binding sites responsible for FXIII binding to immobilized fibrin(ogen) by phage display technology (1999) (0)
- EFFECT OF ANTI-PLATELET DRUGS ON PLATELET AGGREGATION AND THROMBUS FORMATION INDUCED BY HUMAN ATHEROSCLEROTIC PLAQUES (2007) (0)
- thrombosis cells are functionally active in an ex vivo flow model of + blood CD34 immunodeficient (NOD/SCID) mice upon transplantation of human cord Human platelets produced in nonobese diabetic/severe combined (2010) (0)
- A new platelet activation marker specific for activated integrin a2b1: monoclonal antibody IAC-1 (2003) (0)
- Anti-vWF antibody inhibiting vWF-binding to collagen neutralizes shear stress induced platelet-collagen interactions (1999) (0)
- Inhibition of TAFI and PAI-1 protects mice from cerebral ischemia/reperfusion injury (2015) (0)
- Non-receptor-mediated refractoriness in prostacyclin production by human endothelial cells in a continuous flow system is delayed by a low-molecular-weight plasma fraction devoid of reducing cofactors for peroxidase-catalysed reactions. (1990) (0)
- P5119Differences in VWF activity in von willebrand disease type 2A patients versus LVAD patients with the acquired von willebrand syndrome (2018) (0)
- The Novel S527F Mutation in the Integrin 3 Chain Induces a High Affinity IIb3 Receptor by Hindering Adoption of the (2009) (0)
- ADAMTS13 binds to von Willebrand factor multimers in solution via the eighth thrombospondin-1 repeat (2011) (0)
- Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for prevention and treatment of pathological changes in the homeostasis (2000) (0)
- Preparation and characterization of large-format macroporous cryogel disks for use in affinity chromatography and biotechnological applications (2018) (0)
- Alternative detection system of platelet adhesion under flow conditions (2000) (0)
- antithrombotic agents that block the bridge von Willebrand factor (vWF) -colageno). (2001) (0)
- mAb IAC-1 is speciic for the activated form of integrin alpha2beta1 (2003) (0)
- Distinct sequences of the GPIb-binding domain of von Willebrand factor are involved in shear-induced platelet aggregation (1997) (0)
- A Monoclonal-antibody Induces Changes in the Function of Normal Von-willebrand-factor (vwf), That Then Behaves Like Type-iib (1993) (0)
- Anti-CUB1 or Anti-Spacer Antibodies That Increase ADAMTS13 Activity Act By Allosterically Enhancing Metalloprotease Domain Function (2018) (0)
- Thrombus age and composition reflect stroke etiology (2017) (0)
- GPRP interferes with FXIIIa in localization to immobilized Fibrin(ogen) and with platelet deposition in different thrombosis models (2003) (0)
- Phage displayed 6-mer mimotopes with a consensus proline absent in the minimized linear wild-type epitope (2004) (0)
- Local stretching of VWF strings is a trigger for ADAMTS13 mediated proteolysis (2011) (0)
- Open ADAMTS13 Conformation in Immune-Mediated Thrombotic Thrombocytopenic Purpura Is Induced By Anti-ADAMTS13 Autoantibodies and Corresponds with an Ongoing ADAMTS13 Pathology (2018) (0)
- Schmidt,a memorial lecture - peroxides in hemostasis and thrombosis (1985) (0)
- Bm-13.177 specifically blocks the platelet thromboxane receptor (1984) (0)
- ADAMTS13-induced unfolding of the von Willebrand factor A2 domain (2015) (0)
- Non-helical peptide sequence SRHPRVGVYHVFDSA binds specifically to human integrin a2b1 (2005) (0)
- The aggregation of human platelets by monoclonal-antibodies is subtype-dependent (1991) (0)
- Long-term expression of von willebrand factor VIA sleeping beauty sandwich transposon-mediated gene therapy (2015) (0)
- The role of platelet VWF in mice (2013) (0)
- Abstracts of the 8th European Symposium on Platelet and Granulocyte Immunobiology, Seehotel Rust, Rust, Austria, May 13–16, 2004 (2004) (0)
- A new Von Willebrand ristocetin cofactor activity assay based on plasma glycocalicin (2003) (0)
- Von-willebrand-factor binding to endothelial-cell extracellular-matrix collagen type-vi (1995) (0)
- Distinct differences in laboratory findings of patients with von Willebrand disease type 2A versus patients with LVAD-induced acquired von Willebrand syndrome (0)
- Crystal Structure and Paratope Determination of 82D6A3, an Antithrombotic Antibody Directed Against the von Willebrand factor A3-Domain (2005) (0)
- The role of ADAMTS13 and VWF in Patients with Acute Ischemic Stroke: a Case Control Study (2015) (0)
- The flexible tail of the hemostatic enzyme ADAMTS13 is able to shield the active site (2014) (0)
- Towards platelet-specific RNA interference (2011) (0)
- Platelet-specific GARP deficiency does not affect thrombosis and hemostasis in mice (2015) (0)
- Plasma ADAMTS13 adopts a closed conformation in healthy individuals (2016) (0)
- Neutrophil extracellular traps in human ischemic stroke thrombi (2016) (0)
- Crosstalk between integrins a2b1 and aIIbb3 during platelet activation (2005) (0)
- Stabilization of beta-lactoglobulin in alkaline medium by 2-p-toluidinylnaphthalene-6-sulphonate [proceedings]. (1979) (0)
- adenylate cyclase activity human platelets by simultaneous modulation of phospholipase C and Sodium fluoride mimics effects of both agonists and antagonists on intact (2011) (0)
- Collagen-von Willebrand factor-GPIb interaction under shear conditions (1999) (0)
- protein regulating platelet function Transcription profiling in human platelets reveals LRRFIP1 as a novel (2010) (0)
- A novel inhibitory anti-GPIb monoclonal antibody prevents thrombus formation in the baboon (1999) (0)
- The antithrombotic effect of the fucoidan of Lessonia vadosa: a strong inhibitior of the platelet GPIb receptor - von Willebrand factor interaction (2011) (0)
- Fab-fragments of 6B4, an anti-glycoprotein (GP)Ib alpha monoclonal antibody prevent arterial cyclic flow reductions in the baboon, without prolonging the bleeding time (2000) (0)
- A murine monoclonal anti-GPIb antibody inhibits ristocetin- and shear-induced vWf-dependent platelet adhesion and aggregation (1997) (0)
- The Role of GBPIalpha in Phagocytosis of Platelets by Macrophages. (2006) (0)
- Manipulation of Pro- and Antiaggregating Prostaglandins: New Antithrombotic Strategies (1985) (0)
- An existing thrombus partially protects against the formation of a second thrombus in baboons (1999) (0)
- Anti-tail monoclonal antibodies change the conformation of ADAMTS13 into a hyperactive state (2014) (0)
- Targeting vWF and GPIb pathways to attenuate thrombocytopenia in a xenogenic pig-to-baboon liver perfusion model (2013) (0)
- To the editor : A modified Folts model or the original Folts model to evaluate new antithrombotics ? (0)
- Acquired bernard-soulier syndrome and deep venous thrombosis in a patient with vasculitis (1995) (0)
- von Willebrand factor deficiency does not influence angiotensin II-induced abdominal aortic aneurysm formation in mice (2018) (0)
- Differences in mechanisms by which monoclonal murine anti-human platelet antibodies cause aggregation of baboon and human platelets (1993) (0)
- Comparison of von willebrand factor, factor VIII and ADAMTS13 in plasma products used in the treatment of thrombotic thrombocytopenic purpura (2007) (0)
- antibodies is subtype-dependent Human platelet aggregation by murine monoclonal antiplatelet (2011) (0)
- The use of glycocalicin captured from plasma to determine the VWF:RiCo facilitates diagnosis of VWD patients (2003) (0)
- Local stretching of von Willebrand factor strings and its association with ADAMTS13 proteolysis (2010) (0)
- Von Willebrand factor binding to collagen and glycoprotein Ib-alpha, but not glycoprotein IIb/IIIa contributes to ischaemic stroke in mice (2010) (0)
- The epitope/mimotope of a monoclonal antibody, which induces type 2B-like alteration of von Willebrand factor, is localized at the N-terminal end of the mature subunit (1999) (0)
- Monoclonal myelopoiesis and subnormal erythropoietin concentration are independent risk factors for thromboembolic complications in essential thrombocythemia (2003) (0)
- GPIb and GPIIb/IIIa Receptors Regulate Activation and Sequestration of Human Platelets in a Xenogenic Pig Lung Perfusion Model: 1807 (2012) (0)
- Platelet activation by cross-linking of a platelet membrane-protein associated with actin (1995) (0)
- Targeting the collagen – von Willebrand factor – Glycoprotein Ibα binding axis with structure-based drug design (2011) (0)
- Lung xenogenic injury: does anticoagulation help? (2013) (0)
- DISSOCIATION OF PHOSPHOLIPASE A2 ACTIVATION FROM CYTOSOLIC FREE CA2+ MOBILIZATION IN PLATELETS EXPOSED TO FLUORIDE (1987) (0)
- Real-time in depth analysis of single VWF strings and their digestion by ADAMTS13 (2010) (0)
- A murine monoclonal-antibody contains an rgd-sequence in the heavy-chain cdr3 (h3) involved in the inhibition of platelet glycoprotein-iib/iiia function (1993) (0)
- Different functional active conformations of integrin a2b1 are induced dependent on the way platelets are activated. (2006) (0)
- Abstract (2003) (0)
- Platelet integrins alpha2beta1 and alpha IIbbeta3 cross talk during platelet activation (2003) (0)
- Blockade of Glycoproteins Ib and IIb/IIIa Reduces Platelet Sequestration and PVR Rise in a Xenogeneic Lung Perfusion Model (2015) (0)
- Selection of phages from a heptamer library that differentiate between the matrix from HUVEC and HMEC (1999) (0)
- ADAMTS13 containing the naturally occurring mutation p.Arg1177Gln adopts an open conformation (2016) (0)
- neointima formation Inhibition of integrin function by a cyclic RGD-containing peptide prevents (2011) (0)
- Endogenous plasmin activity reverses acute thrombotic thrombocytopenic purpura (2016) (0)
- The regulation of von Willebrand factor A1 domain GPIb-IX-V interaction (2005) (0)
- Fourth European Workshop on Inflammation Wilrijk March 1982 (1982) (0)
- Drugs modulating prostacyclin production as potential antithrombotic agents (1982) (0)
- Von Willebrand factor activity-proof (2000) (0)
- Cell-anchored von Willebrand Factor Local Elongation of Endothelial Enzymology : (2011) (0)
- Inhibition of Phospholipase C in Human Endothelial Cells (1990) (0)
- First assay to accurately determine adamts 13-VWF complexes in plasma (2011) (0)
- Piracetam has an antiplatelet effect invivo and invitro (1991) (0)
- congenital thrombotic thrombocytopenic purpura domain reduces secretion and substrate turnover in a patient with Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease (2009) (0)
- Protein-kinase-c dependent modulation of guanine nucleotide-dependent inhibition of phospholipase-c and concomitant phosphorylation of gz in human endothelial-cells (1991) (0)
- Antithrombotic von Willebrand factor (vWF) collagen bypass inhibitors (2001) (0)
- P3277Distinct differences in laboratory findings of patients with von Willebrand disease type 2A versus patients with LVAD-induced acquired von Willebrand syndrome (2017) (0)
- Inhibition of the shear-induced platelet microparticle formation by a mAb against GPIb alpha is associated with protein tyrosine dephosphorylation and the blockade of filamin cleavage (2004) (0)
- The VWFVWTLPDQC (1129-1136) sequence does not contribute to A3-dependent or independent vWF-binding to collagen I, III and VI (1999) (0)
- Mice Lacking Garp On Platelets Display Unaltered Thrombus Formation (2016) (0)
- Selection of vWF-binding phages that inhibit the interaction of vWF with collagen both under static and flow conditions (1999) (0)
- autoantibody directed against platelet glycoprotein Ia/IIa Production and nucleotide sequence of an inhibitory human IgM (2011) (0)
- Pig-to-Baboon Liver Xenoperfusion Utilizing GalTKO.hCD46 Pigs and Glycoprotein Ib Blockade. (2014) (0)
- Chain-folding prediction of the bovine beta-lactoglobulins (1978) (0)
- Thrombus composition reflects stroke etiology (2016) (0)
- Human platelet glycoprotein VI: Identification of residues involved in the binding to collagen (2004) (0)
- Whole-blood prostacyclin production in children with hus (1982) (0)
- Integrin crosstalk 8th International Symposium on Platelet and Granulocyte Immunobiology (2004) (0)
- Subject Index, Vol. 17, 1987 (1987) (0)
- GARP deficiency in murine platelets or endothelial cells does neither affect hemostasis nor thrombosis (2016) (0)
- Selection by phage display technology of epitopes for the collagen-binding domain of von Willebrand factor (vWF) (1997) (0)
- Selection of specific peptides by phage display technology as affinity ligands to purify human lactoferrin from milk with expanded bed adsorption (2003) (0)
- Drug Inhibition of GPIb. (2009) (0)
- NEW INSIGHTS IN ADAMTS13 PHYSIOLOGY BY MEASURING ACTIVITY OVER ANTIGEN RATIO (2007) (0)
- Single molecule visualization of ADAMTS13 enzymes on EC-anchored VWF strings (2011) (0)
- Endogenous plasmin levels control the development of acute episodes of thrombotic thrombocytopenic purpura in mice (2015) (0)
- THE DISTURBED MULTIMER PATTERN OF VWF R1374C IS NOT DUE TO INCREASED ADAMTS13 MEDIATED PROTEOLYSIS (2007) (0)
- Effect of near UV irradiation on a single chain variable fragment of the monoclonal antibody 82D6A3 and its mutants (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hans Deckmyn?
Hans Deckmyn is affiliated with the following schools:
